# A Study of a Weight Loss Intervention in People With Endometrial Cancer

> **NCT06751589** · EARLY_PHASE1 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 36 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT06751589
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-19
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06751589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06751589, "A Study of a Weight Loss Intervention in People With Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06751589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*